Index RUT
P/E 6.77
EPS (ttm) 3.83
Insider Own 17.27%
Shs Outstand 14.68M
Perf Week -1.56%
Market Cap 380.80M
Forward P/E 6.49
EPS next Y 4.00
Insider Trans 0.00%
Shs Float 12.15M
Perf Month -1.43%
Income 54.34M
PEG 0.85
EPS next Q 1.07
Inst Own 36.24%
Short Float 0.67%
Perf Quarter -16.73%
Sales 263.33M
P/S 1.45
EPS this Y 4.99%
Inst Trans 0.62%
Short Ratio 3.28
Perf Half Y 13.28%
Book/sh 28.96
P/B 0.90
EPS next Y 0.00%
ROA 1.29%
Short Interest 0.08M
Perf Year 21.21%
Cash/sh -
P/C -
EPS next 5Y 8.00%
ROE 13.90%
52W Range 17.06 - 31.49
Perf YTD -15.48%
Dividend Est. 0.80 (3.08%)
P/FCF 5.72
EPS past 5Y 11.04%
ROI 9.50%
52W High -17.62%
Beta 0.39
Dividend TTM 0.86 (3.32%)
Quick Ratio -
Sales past 5Y 19.74%
Gross Margin -
52W Low 52.05%
ATR (14) 0.62
Dividend Ex-Date Mar 14, 2024
Current Ratio 0.02
EPS Y/Y TTM -6.25%
Oper. Margin 29.18%
RSI (14) 45.57
Volatility 2.01% 2.11%
Employees 496
Debt/Eq 0.99
Sales Y/Y TTM 49.02%
Profit Margin 20.63%
Recom 3.00
Target Price 30.00
Option/Short Yes / Yes
LT Debt/Eq 0.30
EPS Q/Q -3.91%
Payout 22.03%
Rel Volume 0.31
Prev Close 25.78
Sales Surprise 0.20%
EPS Surprise 0.91%
Sales Q/Q 37.60%
Earnings Jan 25 BMO
Avg Volume 24.99K
Price 25.94
SMA20 -0.86%
SMA50 -4.72%
SMA200 5.48%
Trades
Volume 1,247
Change 0.62%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-30-21 Upgrade
Piper Sandler
Neutral → Overweight
$25 → $26
Sep-25-17 Downgrade
Sandler O'Neill
Buy → Hold
Nov-27-07 Downgrade
Janney Mntgmy Scott
Buy → Neutral
Feb-23-24 09:00AM
Jan-26-24 08:00AM
Jan-25-24 12:34PM
10:47AM
06:21AM
(Associated Press Finance)
06:00AM
Loading…
06:00AM
Dec-06-23 02:07PM
Dec-05-23 09:40AM
Nov-28-23 03:41PM
Oct-27-23 02:52PM
07:30AM
Oct-26-23 06:10AM
(Associated Press Finance)
06:00AM
Oct-02-23 12:00PM
10:00AM
01:01AM
Loading…
Sep-15-23 01:01AM
Sep-08-23 07:10PM
Sep-06-23 10:01AM
Aug-31-23 08:35AM
03:20AM
Aug-30-23 06:06PM
09:40AM
Aug-28-23 12:42PM
Aug-25-23 04:00PM
03:20PM
(American City Business Journals)
Aug-24-23 09:38PM
(American City Business Journals)
04:45PM
Aug-06-23 08:22AM
Jul-27-23 06:18AM
06:00AM
09:28AM
Loading…
Jul-02-23 09:28AM
Jun-09-23 06:08AM
May-25-23 03:45PM
May-21-23 01:37PM
May-12-23 11:00AM
May-05-23 06:58AM
May-04-23 06:29AM
May-03-23 06:46AM
May-02-23 06:46AM
May-01-23 06:45AM
Apr-28-23 07:04AM
Apr-27-23 06:47AM
06:08AM
06:00AM
Apr-26-23 06:26AM
Apr-20-23 07:03AM
Apr-19-23 06:53AM
Apr-17-23 06:54AM
Apr-14-23 06:37AM
Apr-13-23 06:52AM
Apr-12-23 07:07AM
Apr-11-23 06:58AM
Apr-10-23 06:44AM
Apr-09-23 08:24AM
Apr-07-23 07:44AM
Apr-06-23 07:20AM
Apr-05-23 06:11AM
Apr-04-23 07:08AM
Apr-03-23 06:48AM
06:00AM
Mar-31-23 06:36AM
Mar-30-23 06:36AM
Mar-29-23 06:32AM
Mar-28-23 06:46AM
Mar-24-23 06:42AM
Mar-23-23 07:01AM
Mar-21-23 06:23AM
Mar-20-23 06:35AM
Mar-17-23 06:47AM
Mar-16-23 06:51AM
Mar-15-23 06:44AM
Mar-13-23 06:32AM
Mar-10-23 07:04AM
Mar-09-23 06:33AM
Mar-08-23 06:30AM
Mar-07-23 06:34AM
Mar-06-23 07:22AM
Mar-03-23 06:38AM
Mar-02-23 06:44AM
Mar-01-23 06:01AM
Feb-28-23 06:43AM
Feb-27-23 06:50AM
05:14AM
Feb-24-23 01:16PM
07:17AM
Feb-23-23 07:21AM
Feb-22-23 06:56AM
Feb-21-23 07:35AM
Feb-17-23 06:27AM
Feb-16-23 07:28AM
Feb-15-23 07:01AM
Feb-06-23 05:19AM
Jan-27-23 08:28AM
Jan-26-23 07:25AM
06:00AM
Jan-23-23 06:27AM
Dec-12-22 09:57AM
Dec-09-22 07:51AM
Nov-30-22 01:47PM
Nov-17-22 04:40PM
Summit Financial Group, Inc. is a holding company, which engages in the provision of community banking and insurance services. The company was founded on March 5, 1987 and is headquartered in Moorefield, WV.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
HINKLE GARY L Director Sep 14 '23 Buy 24.07 3,367 81,044 424,055 Sep 14 11:51 AM HINKLE GARY L Director Sep 13 '23 Buy 24.20 10,710 259,182 420,688 Sep 14 11:51 AM HINKLE GARY L Director Sep 12 '23 Buy 24.17 124 2,997 409,978 Sep 14 11:51 AM Upson Jill S Director Aug 29 '23 Buy 24.81 1,850 45,895 2,207 Aug 30 11:05 AM JENNINGS SCOTT C EVP & COO May 04 '23 Buy 18.17 1,000 18,168 14,595 May 05 10:42 AM BEAN OSCAR M Chairman of the Board May 02 '23 Buy 18.55 242 4,490 83,334 May 02 02:42 PM Hager Joseph EVP & Chief Risk Officer May 01 '23 Buy 19.62 3,000 58,860 3,000 May 01 04:41 PM
Index -
P/E -
EPS (ttm) -0.94
Insider Own 25.98%
Shs Outstand 26.33M
Perf Week -3.46%
Market Cap 58.72M
Forward P/E -
EPS next Y -0.59
Insider Trans -0.22%
Shs Float 19.49M
Perf Month 53.79%
Income -14.64M
PEG -
EPS next Q -0.14
Inst Own 11.79%
Short Float 0.68%
Perf Quarter -1.76%
Sales 0.00M
P/S -
EPS this Y 9.72%
Inst Trans -3.60%
Short Ratio 0.75
Perf Half Y 6.70%
Book/sh 0.61
P/B 3.68
EPS next Y 9.23%
ROA -138.30%
Short Interest 0.13M
Perf Year 1.36%
Cash/sh 0.61
P/C 3.63
EPS next 5Y -
ROE -159.89%
52W Range 1.06 - 3.74
Perf YTD -5.11%
Dividend Est. -
P/FCF -
EPS past 5Y -82.01%
ROI -91.86%
52W High -40.37%
Beta -1.22
Dividend TTM -
Quick Ratio 14.09
Sales past 5Y 0.00%
Gross Margin -
52W Low 110.38%
ATR (14) 0.20
Dividend Ex-Date -
Current Ratio 14.09
EPS Y/Y TTM 41.18%
Oper. Margin 0.00%
RSI (14) 58.60
Volatility 10.22% 12.58%
Employees 15
Debt/Eq 0.00
Sales Y/Y TTM -
Profit Margin -
Recom 1.00
Target Price 6.78
Option/Short No / Yes
LT Debt/Eq 0.00
EPS Q/Q 68.21%
Payout -
Rel Volume 0.39
Prev Close 2.22
Sales Surprise -
EPS Surprise 156.77%
Sales Q/Q -
Earnings Mar 20 AMC
Avg Volume 175.29K
Price 2.23
SMA20 7.63%
SMA50 19.98%
SMA200 10.74%
Trades
Volume 11,077
Change 0.45%
Mar-20-24 08:53PM
04:05PM
Mar-14-24 08:31AM
Mar-07-24 08:31AM
Mar-05-24 08:31AM
09:00AM
Loading…
Jan-31-24 09:00AM
Dec-14-23 08:31AM
Nov-15-23 02:30PM
Nov-14-23 04:01PM
Nov-09-23 08:31AM
Nov-07-23 08:31AM
Oct-31-23 08:31AM
Sep-27-23 08:05AM
Sep-26-23 08:31AM
Sep-21-23 09:35AM
06:17AM
Loading…
Aug-15-23 06:17AM
Aug-11-23 01:43PM
(Thomson Reuters StreetEvents)
Aug-10-23 04:01PM
Aug-09-23 08:31AM
Aug-08-23 08:31AM
Jul-27-23 08:31AM
Jul-26-23 08:31AM
Jul-21-23 07:04AM
Jun-08-23 08:31AM
May-30-23 08:00AM
May-25-23 08:31AM
May-18-23 08:31AM
May-11-23 04:01PM
May-03-23 08:31AM
Mar-20-23 03:05AM
04:01PM
Loading…
Mar-16-23 04:01PM
Mar-14-23 08:31AM
Mar-08-23 08:31AM
Mar-07-23 07:15AM
Mar-02-23 08:31AM
Jan-24-23 08:31AM
Jan-12-23 08:05AM
Jan-05-23 08:31AM
Dec-29-22 08:31AM
Dec-07-22 08:31AM
Nov-16-22 10:17AM
08:45AM
Nov-10-22 04:01PM
Oct-25-22 08:31AM
Oct-13-22 08:31AM
Oct-11-22 08:31AM
Oct-06-22 08:31AM
Sep-29-22 08:31AM
Sep-28-22 08:31AM
06:16AM
Sep-20-22 08:31AM
Sep-15-22 03:47PM
(Yahoo Finance Video) +85.60%
08:31AM
Sep-12-22 08:31AM
Aug-16-22 08:42AM
Aug-11-22 04:01PM
Aug-04-22 08:45AM
Jul-28-22 08:31AM
Jul-26-22 08:31AM
Jul-21-22 09:30AM
Jun-30-22 08:31AM
May-25-22 08:31AM
May-18-22 08:31AM
May-12-22 04:01PM
Apr-28-22 08:31AM
Apr-19-22 04:01PM
Mar-24-22 04:01PM
Mar-10-22 08:31AM
Mar-07-22 08:31AM
Mar-02-22 08:31AM
Feb-11-22 05:05AM
Feb-02-22 05:21PM
Jan-27-22 09:42AM
Jan-11-22 04:19PM
Dec-29-21 08:31AM
Dec-22-21 08:31AM
Dec-16-21 04:01PM
Nov-17-21 08:31AM
Nov-10-21 10:10PM
Feb-02-21 06:50PM
Jan-25-21 01:30PM
Jan-08-21 12:13AM
Jan-07-21 01:55PM
10:09AM
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
de Urioste George Director Sep 29 '23 Sale 2.06 5,500 11,330 36,129 Oct 03 07:18 PM de Urioste George Director Sep 28 '23 Sale 2.04 8,000 16,320 41,629 Sep 29 07:41 PM de Urioste George Director Sep 27 '23 Sale 2.11 1,834 3,870 49,629 Sep 29 07:41 PM de Urioste George Director Sep 26 '23 Sale 2.09 5,000 10,450 51,463 Sep 27 12:01 PM de Urioste George Director Sep 22 '23 Sale 2.21 2,393 5,289 56,463 Sep 27 12:01 PM de Urioste George Director Sep 21 '23 Sale 2.41 100 241 58,856 Sep 22 07:07 PM de Urioste George Director Sep 20 '23 Sale 2.46 883 2,172 58,956 Sep 22 07:07 PM de Urioste George Director Sep 18 '23 Sale 2.46 5,000 12,300 59,839 Sep 19 06:51 PM de Urioste George Director Sep 15 '23 Sale 2.43 4,269 10,374 64,839 Sep 19 06:51 PM de Urioste George Director Sep 14 '23 Sale 2.17 5,000 10,850 69,108 Sep 15 05:36 PM de Urioste George Director Sep 13 '23 Sale 1.93 5,000 9,656 74,108 Sep 15 05:36 PM
Index -
P/E 11.97
EPS (ttm) 1.94
Insider Own 6.00%
Shs Outstand 13.65M
Perf Week 0.76%
Market Cap 316.42M
Forward P/E 6.39
EPS next Y 3.63
Insider Trans 0.00%
Shs Float 11.52M
Perf Month -1.80%
Income 22.80M
PEG -
EPS next Q 0.95
Inst Own 20.30%
Short Float 0.41%
Perf Quarter -10.45%
Sales 138.80M
P/S 2.28
EPS this Y -48.30%
Inst Trans -3.62%
Short Ratio 0.45
Perf Half Y -9.51%
Book/sh 27.55
P/B 0.84
EPS next Y 180.88%
ROA 2.00%
Short Interest 0.05M
Perf Year -4.39%
Cash/sh 3.44
P/C 6.73
EPS next 5Y -
ROE 6.50%
52W Range 22.35 - 28.87
Perf YTD -10.38%
Dividend Est. -
P/FCF -
EPS past 5Y -6.80%
ROI 3.00%
52W High -19.73%
Beta 1.34
Dividend TTM 2.86 (12.34% )
Quick Ratio -
Sales past 5Y 20.70%
Gross Margin 44.60%
52W Low 3.69%
ATR (14) 0.29
Dividend Ex-Date Mar 12, 2024
Current Ratio -
EPS Y/Y TTM -
Oper. Margin 38.30%
RSI (14) 50.36
Volatility 0.98% 1.12%
Employees -
Debt/Eq 2.26
Sales Y/Y TTM -
Profit Margin 16.40%
Recom 2.10
Target Price 26.04
Option/Short Yes / Yes
LT Debt/Eq 2.26
EPS Q/Q -161.40%
Payout 145.60%
Rel Volume 1.31
Prev Close 22.95
Sales Surprise 1.26%
EPS Surprise -2.25%
Sales Q/Q 38.00%
Earnings Jan 09 AMC
Avg Volume 105.37K
Price 23.17
SMA20 0.02%
SMA50 -0.21%
SMA200 -7.56%
Trades
Volume 22,294
Change 0.98%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-10-24 Downgrade
Compass Point
Buy → Neutral
Jan-08-24 Downgrade
B. Riley Securities
Buy → Neutral
$28
Oct-11-23 Downgrade
Hovde Group
Outperform → Market Perform
$27
Jul-12-23 Downgrade
Raymond James
Outperform → Mkt Perform
Apr-24-23 Initiated
Janney
Buy
$27
Dec-13-22 Resumed
B. Riley Securities
Buy
$27.50
Jun-22-21 Initiated
Raymond James
Outperform
$30
Jun-16-21 Initiated
Oppenheimer
Outperform
$29
Mar-05-21 Initiated
Hovde Group
Outperform
$29
Jan-07-21 Upgrade
Janney
Neutral → Buy
Jan-13-20 Upgrade
Ladenburg Thalmann
Neutral → Buy
Jan-09-20 Upgrade
Compass Point
Neutral → Buy
$27.75
Dec-19-19 Initiated
National Securities
Neutral
$26
Oct-30-18 Upgrade
Ladenburg Thalmann
Neutral → Buy
Mar-27-18 Initiated
B. Riley FBR, Inc.
Buy
$23.50
Oct-13-17 Upgrade
Compass Point
Neutral → Buy
Oct-06-17 Initiated
Janney
Neutral
Sep-07-17 Initiated
Maxim Group
Buy
$23
Jul-26-16 Initiated
Compass Point
Neutral
$18
Jul-01-15 Initiated
Cantor Fitzgerald
Buy
Show Previous Ratings
Feb-15-24 08:30AM
Jan-11-24 09:19AM
01:22AM
(Thomson Reuters StreetEvents)
Jan-09-24 10:48PM
09:52PM
04:20PM
Loading…
04:20PM
(Associated Press Finance)
04:05PM
Dec-28-23 08:30AM
Nov-15-23 08:30AM
Oct-13-23 09:55AM
Oct-11-23 09:36AM
Oct-10-23 11:58PM
(Thomson Reuters StreetEvents)
06:43AM
Oct-09-23 05:15PM
04:13PM
(Associated Press Finance)
04:05PM
Loading…
04:05PM
Sep-27-23 10:40AM
Sep-18-23 05:50PM
Sep-13-23 07:14AM
Aug-15-23 04:05PM
Jul-20-23 05:14AM
Jul-14-23 12:41AM
Jul-12-23 06:37AM
04:28AM
(Thomson Reuters StreetEvents)
Jul-10-23 05:25PM
04:17PM
04:08PM
Jun-26-23 08:30AM
Jun-01-23 06:12AM
May-22-23 08:30AM
05:36AM
Loading…
May-08-23 05:36AM
May-04-23 03:36AM
(Thomson Reuters StreetEvents)
May-02-23 06:05PM
05:05PM
04:05PM
Apr-28-23 12:10PM
Apr-26-23 10:02AM
Apr-25-23 10:01AM
Apr-18-23 08:30AM
Apr-11-23 05:26PM
08:09AM
Mar-09-23 05:15AM
Mar-08-23 08:16AM
Mar-03-23 05:03AM
Mar-01-23 01:47AM
Feb-28-23 08:30AM
Jan-17-23 12:20PM
Jan-13-23 02:44PM
Jan-12-23 12:29PM
10:30AM
Jan-10-23 05:25PM
04:05PM
Jan-03-23 10:00AM
09:41AM
Dec-21-22 08:30AM
Dec-09-22 12:00PM
Dec-05-22 05:31PM
07:57AM
Nov-22-22 04:36AM
Nov-15-22 08:30AM
Nov-01-22 12:20PM
Oct-25-22 09:55AM
Oct-19-22 05:32PM
08:08AM
Oct-04-22 05:25PM
04:05PM
Oct-03-22 08:30AM
Sep-29-22 08:30AM
Sep-20-22 08:30AM
Sep-08-22 05:55PM
Sep-06-22 06:15PM
Sep-01-22 09:53AM
Aug-29-22 08:30AM
Aug-16-22 09:00AM
Jul-27-22 10:10AM
Jul-07-22 04:00PM
Jul-06-22 05:27PM
04:05PM
Jun-23-22 08:30AM
Jun-08-22 05:35PM
May-26-22 06:50AM
May-25-22 06:54AM
May-10-22 04:31PM
May-06-22 12:30AM
May-04-22 07:45PM
04:05PM
Apr-28-22 05:45PM
Apr-21-22 04:05PM
Apr-19-22 05:30PM
Apr-18-22 05:05PM
Feb-24-22 08:30AM
Feb-17-22 01:30PM
Jan-19-22 04:05PM
Jan-13-22 04:42PM
Jan-07-22 11:26AM
Jan-06-22 10:00PM
Jan-05-22 05:25PM
04:05PM
Dec-29-21 03:00PM
Dec-23-21 01:36PM
Saratoga Investment Corp. is a business development company specializing in leveraged and management buyouts, acquisition financings, growth financings, recapitalization, debt refinancing, and transitional financing transactions at the lower end of middle market companies. It structures its investments as debt and equity by investing through first and second lien loans, mezzanine debt, co-investments, select high yield bonds, senior secured bonds, unsecured bonds, and preferred and common equity. The firm prefers to invest in aerospace, automotive aftermarket and services, business products and services, consumer products and services, education, environmental services, industrial services, financial services, food and beverage, healthcare products and services, logistics, distribution, manufacturing, restaurants services, food services, software services, technology services, specialty chemical, media and telecommunications. It seeks to invest in the United States. The firm primarily invests $5 million to $50 million in companies having EBITDA of $2 million or greater and revenues of $8 million to $250 million. The firm prefer to take a majority stake. It invests through direct lending as well as participation in loan syndicates. The firm was formerly known as GSC Investment Corp. Saratoga Investment Corp. was formed on 2007 and is based in New York, New York with an additional office in Florham Park, New Jersey.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Oberbeck Christian L CEO, Director and President May 04 '23 Buy 23.81 2,000 47,620 689,775 May 08 02:54 PM
Index RUT
P/E -
EPS (ttm) -3.94
Insider Own 38.44%
Shs Outstand 61.47M
Perf Week -6.24%
Market Cap 2.22B
Forward P/E -
EPS next Y -3.00
Insider Trans -9.62%
Shs Float 49.93M
Perf Month 9.53%
Income -235.94M
PEG -
EPS next Q -0.79
Inst Own 52.80%
Short Float 13.66%
Perf Quarter 100.59%
Sales 0.00M
P/S -
EPS this Y 16.12%
Inst Trans -3.35%
Short Ratio 3.01
Perf Half Y 218.14%
Book/sh 1.49
P/B 18.42
EPS next Y 9.39%
ROA -100.10%
Short Interest 6.82M
Perf Year 145.82%
Cash/sh 1.52
P/C 18.03
EPS next 5Y -
ROE -137.31%
52W Range 6.40 - 30.27
Perf YTD 105.71%
Dividend Est. -
P/FCF -
EPS past 5Y -106.26%
ROI -206.99%
52W High -9.61%
Beta 0.95
Dividend TTM -
Quick Ratio 2.53
Sales past 5Y 0.00%
Gross Margin -
52W Low 327.50%
ATR (14) 1.99
Dividend Ex-Date -
Current Ratio 2.53
EPS Y/Y TTM -21.58%
Oper. Margin 0.00%
RSI (14) 54.28
Volatility 8.72% 8.02%
Employees 141
Debt/Eq 0.30
Sales Y/Y TTM -
Profit Margin -
Recom 1.00
Target Price 37.56
Option/Short Yes / Yes
LT Debt/Eq 0.25
EPS Q/Q -46.68%
Payout -
Rel Volume 0.42
Prev Close 28.50
Sales Surprise -
EPS Surprise -18.90%
Sales Q/Q -
Earnings Mar 05 BMO
Avg Volume 2.26M
Price 27.36
SMA20 0.67%
SMA50 15.73%
SMA200 95.11%
Trades
Volume 155,834
Change -4.00%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-20-24 Initiated
H.C. Wainwright
Buy
$36
Feb-27-23 Upgrade
Raymond James
Outperform → Strong Buy
$16 → $27
Feb-15-23 Initiated
Oppenheimer
Outperform
$34
Jan-26-23 Initiated
Guggenheim
Buy
$33
Jul-20-22 Initiated
Chardan Capital Markets
Buy
$17
Jul-12-22 Initiated
Raymond James
Outperform
$15
Oct-12-20 Initiated
Stifel
Buy
$29
Oct-12-20 Initiated
Piper Sandler
Overweight
$34
Oct-12-20 Initiated
JP Morgan
Overweight
$27
Oct-12-20 Initiated
Jefferies
Buy
$47
Mar-27-24 04:05PM
08:30AM
Mar-25-24 12:28PM
(Associated Press Finance) -7.72%
07:30AM
Mar-13-24 07:30AM
01:19PM
Loading…
Mar-07-24 01:19PM
Mar-05-24 10:53AM
07:30AM
Mar-02-24 12:00AM
Feb-29-24 03:02AM
Feb-14-24 04:15PM
Feb-01-24 07:30AM
Jan-26-24 11:01PM
Jan-22-24 10:14PM
Jan-12-24 01:12PM
04:05PM
Loading…
Jan-11-24 04:05PM
Jan-05-24 09:02AM
07:30AM
Jan-04-24 10:46PM
04:37PM
12:39PM
Jan-03-24 04:25PM
02:46PM
(The Wall Street Journal)
02:01PM
(The Wall Street Journal)
08:19AM
06:30AM
Jan-02-24 04:05PM
Nov-13-23 06:59PM
Nov-07-23 07:30AM
Oct-31-23 05:36AM
01:11AM
Loading…
01:11AM
Oct-30-23 07:30AM
Sep-28-23 07:30AM
Sep-20-23 04:05PM
Sep-15-23 01:52PM
Sep-14-23 01:22PM
Sep-05-23 07:30AM
Aug-28-23 10:22AM
Aug-03-23 07:30AM
Jun-16-23 08:46AM
Jun-01-23 07:30AM
May-25-23 07:30AM
May-17-23 11:25AM
07:30AM
May-11-23 07:30AM
May-03-23 07:35AM
May-02-23 04:46PM
Mar-23-23 07:30AM
Mar-20-23 07:30AM
Mar-07-23 07:30AM
Mar-02-23 07:30AM
Mar-01-23 09:00AM
(Yahoo Finance Video) +5.82%
Feb-27-23 04:40PM
Feb-05-23 05:03AM
Jan-19-23 08:23AM
Jan-18-23 08:49AM
Jan-10-23 12:00PM
Jan-03-23 07:30AM
Dec-16-22 09:55AM
Dec-09-22 09:55AM
Dec-08-22 08:10AM
Nov-30-22 09:55AM
Nov-03-22 07:30AM
Nov-02-22 07:30AM
Oct-31-22 07:30AM
Oct-12-22 06:45AM
(American City Business Journals)
Oct-11-22 04:10PM
Sep-27-22 07:30AM
Sep-12-22 07:00AM
Sep-06-22 04:30PM
07:01AM
07:00AM
Aug-29-22 07:30AM
Aug-10-22 07:30AM
Aug-04-22 07:30AM
Jul-18-22 10:00AM
Jul-12-22 02:54PM
07:30AM
Jul-05-22 07:30AM
Jul-01-22 06:58AM
Jun-03-22 07:30AM
May-16-22 07:30AM
May-02-22 04:05PM
Mar-17-22 08:45AM
Mar-10-22 07:30AM
Mar-03-22 07:30AM
Feb-02-22 01:38PM
Jan-22-22 08:06AM
Jan-18-22 04:18PM
08:00AM
Jan-05-22 07:30AM
Dec-03-21 03:30PM
Dec-02-21 08:30AM
Nov-04-21 07:30AM
Oct-26-21 10:41AM
Oct-13-21 07:45AM
Oct-01-21 10:21AM
07:30AM
Sep-28-21 07:30AM
Sep-27-21 07:30AM
Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Farwell Wildon Chief Medical Officer Mar 12 '24 Sale 25.58 1,030 26,347 150,560 Mar 12 09:58 PM Brumm Joshua T CEO & President Mar 11 '24 Option Exercise 5.54 50,000 277,000 604,385 Mar 12 09:56 PM McNeill Jonathan Chief Business Officer Mar 11 '24 Option Exercise 5.54 17,825 98,750 159,009 Mar 13 06:04 AM Brumm Joshua T CEO & President Mar 11 '24 Sale 25.67 66,387 1,704,142 537,998 Mar 12 09:56 PM McNeill Jonathan Chief Business Officer Mar 11 '24 Sale 25.50 19,601 499,842 139,408 Mar 13 06:04 AM Scalzo Richard William SVP, Head of Finance & Admin. Mar 11 '24 Sale 25.28 2,672 67,542 119,283 Mar 12 09:57 PM HIGH SUSANNA GATTI Chief Operating Officer Mar 11 '24 Sale 25.70 2,292 58,904 156,800 Mar 13 06:04 AM Beskrovnaya Oxana Chief Scientific Officer Mar 11 '24 Sale 25.70 2,081 53,482 152,352 Mar 12 09:42 PM Farwell Wildon Chief Medical Officer Mar 11 '24 Sale 25.70 1,585 40,734 151,590 Mar 12 09:58 PM Brumm Joshua T CEO & President Mar 08 '24 Option Exercise 5.54 363,343 2,012,920 917,728 Mar 12 09:56 PM McNeill Jonathan Chief Business Officer Mar 08 '24 Option Exercise 5.54 90,000 498,600 231,184 Mar 13 06:04 AM Scalzo Richard William SVP, Head of Finance & Admin. Mar 08 '24 Option Exercise 5.54 86,252 477,836 208,207 Mar 12 09:57 PM Brumm Joshua T CEO & President Mar 08 '24 Sale 25.93 363,343 9,421,634 554,385 Mar 12 09:56 PM McNeill Jonathan Chief Business Officer Mar 08 '24 Sale 26.24 90,000 2,361,531 141,184 Mar 13 06:04 AM Scalzo Richard William SVP, Head of Finance & Admin. Mar 08 '24 Sale 26.22 86,252 2,261,465 121,955 Mar 12 09:57 PM HIGH SUSANNA GATTI Chief Operating Officer Mar 08 '24 Sale 26.67 27,199 725,344 159,092 Mar 13 06:04 AM Farwell Wildon Chief Medical Officer Mar 07 '24 Sale 25.86 9,921 256,585 153,175 Mar 11 09:52 PM Brumm Joshua T CEO & President Mar 07 '24 Sale 25.85 9,086 234,873 554,385 Mar 11 09:57 PM McNeill Jonathan Chief Business Officer Mar 07 '24 Sale 25.85 2,434 62,919 141,184 Mar 11 09:50 PM Beskrovnaya Oxana Chief Scientific Officer Mar 07 '24 Sale 25.85 2,373 61,342 154,433 Mar 11 09:56 PM Scalzo Richard William SVP, Head of Finance & Admin. Mar 07 '24 Sale 25.85 2,273 58,757 121,955 Mar 11 09:45 PM HIGH SUSANNA GATTI Chief Operating Officer Mar 07 '24 Sale 25.85 1,591 41,127 186,291 Mar 11 09:56 PM Brumm Joshua T CEO & President Mar 01 '24 Option Exercise 5.54 94,480 523,419 657,951 Mar 01 09:38 PM McNeill Jonathan Chief Business Officer Mar 01 '24 Option Exercise 0.73 24,260 17,710 167,878 Mar 01 09:37 PM Scalzo Richard William SVP, Head of Finance & Admin. Mar 01 '24 Option Exercise 1.03 9,311 9,590 133,539 Mar 01 09:37 PM Brumm Joshua T CEO & President Mar 01 '24 Sale 29.04 94,480 2,743,718 563,471 Mar 01 09:38 PM Rhodes Jason P Director Mar 01 '24 Sale 30.05 46,534 1,398,347 847,388 Mar 05 05:08 PM Atlas Venture Opportunity Fund 10% Owner Mar 01 '24 Sale 30.05 29,435 884,522 1,458,691 Mar 05 05:07 PM McNeill Jonathan Chief Business Officer Mar 01 '24 Sale 28.63 24,260 694,495 143,618 Mar 01 09:37 PM Atlas Venture Opportunity Fund 10% Owner Mar 01 '24 Sale 30.05 17,099 513,825 847,388 Mar 05 05:07 PM Scalzo Richard William SVP, Head of Finance & Admin. Mar 01 '24 Sale 28.25 9,311 262,999 124,228 Mar 01 09:37 PM Brumm Joshua T CEO & President Feb 29 '24 Option Exercise 5.54 5,520 30,581 568,991 Mar 01 09:38 PM Scalzo Richard William SVP, Head of Finance & Admin. Feb 29 '24 Option Exercise 1.03 3,429 3,532 127,657 Mar 01 09:37 PM McNeill Jonathan Chief Business Officer Feb 29 '24 Option Exercise 0.73 4,268 3,116 147,886 Mar 01 09:37 PM Brumm Joshua T CEO & President Feb 29 '24 Sale 27.50 5,520 151,800 563,471 Mar 01 09:38 PM McNeill Jonathan Chief Business Officer Feb 29 '24 Sale 27.50 4,268 117,370 143,618 Mar 01 09:37 PM Scalzo Richard William SVP, Head of Finance & Admin. Feb 29 '24 Sale 27.50 3,429 94,298 124,228 Mar 01 09:37 PM Rhodes Jason P Director Feb 28 '24 Sale 24.84 190,920 4,741,804 864,487 Feb 28 07:15 PM Atlas Venture Fund XI, L.P. 10% Owner Feb 28 '24 Sale 24.84 154,674 3,841,576 5,698,091 Feb 28 07:13 PM Atlas Venture Fund XI, L.P. 10% Owner Feb 28 '24 Sale 24.84 36,246 900,228 864,487 Feb 28 07:13 PM Rhodes Jason P Director Feb 27 '24 Sale 24.41 368,699 8,998,426 877,806 Feb 28 07:15 PM Atlas Venture Fund XI, L.P. 10% Owner Feb 27 '24 Sale 24.41 298,702 7,290,088 5,852,765 Feb 28 07:13 PM Atlas Venture Fund XI, L.P. 10% Owner Feb 27 '24 Sale 24.41 69,997 1,708,338 877,806 Feb 28 07:13 PM Rhodes Jason P Director Feb 26 '24 Sale 23.72 248,219 5,886,673 903,527 Feb 28 07:15 PM Atlas Venture Fund XI, L.P. 10% Owner Feb 26 '24 Sale 23.72 201,095 4,769,096 6,151,467 Feb 28 07:13 PM Atlas Venture Fund XI, L.P. 10% Owner Feb 26 '24 Sale 23.72 47,124 1,117,577 903,527 Feb 28 07:13 PM Rhodes Jason P Director Feb 23 '24 Sale 22.70 196,928 4,470,266 920,843 Feb 23 06:59 PM Atlas Venture Fund XI, L.P. 10% Owner Feb 23 '24 Sale 22.70 159,542 3,621,603 6,352,562 Feb 23 06:58 PM Atlas Venture Fund XI, L.P. 10% Owner Feb 23 '24 Sale 22.70 37,386 848,662 920,843 Feb 23 06:58 PM Atlas Venture Fund XI, L.P. 10% Owner Feb 22 '24 Sale 22.66 119,360 2,704,698 6,512,104 Feb 23 06:58 PM Rhodes Jason P Director Feb 22 '24 Sale 22.66 119,360 2,704,698 6,512,104 Feb 23 06:59 PM Rhodes Jason P Director Feb 21 '24 Sale 22.57 184,501 4,164,817 6,631,464 Feb 23 06:59 PM Atlas Venture Fund XI, L.P. 10% Owner Feb 21 '24 Sale 22.57 184,501 4,164,817 6,631,464 Feb 23 06:58 PM Rhodes Jason P Director Feb 20 '24 Sale 22.72 169,539 3,852,653 6,815,965 Feb 20 06:36 PM Atlas Venture Fund XI, L.P. 10% Owner Feb 20 '24 Sale 22.72 169,539 3,852,653 6,815,965 Feb 20 06:35 PM Atlas Venture Fund XI, L.P. 10% Owner Feb 16 '24 Sale 23.14 162,707 3,765,040 6,985,504 Feb 20 06:35 PM Rhodes Jason P Director Feb 16 '24 Sale 23.14 162,707 3,765,040 6,985,504 Feb 20 06:36 PM Rhodes Jason P Director Feb 15 '24 Sale 23.89 177,906 4,249,600 7,148,211 Feb 20 06:36 PM Atlas Venture Fund XI, L.P. 10% Owner Feb 15 '24 Sale 23.89 177,906 4,249,600 7,148,211 Feb 20 06:35 PM Farwell Wildon Chief Medical Officer Feb 12 '24 Sale 25.07 5,493 137,710 163,503 Feb 14 04:27 PM McNeill Jonathan Chief Business Officer Jan 26 '24 Option Exercise 0.73 20,000 14,600 163,618 Jan 26 07:48 PM Scalzo Richard William SVP, Head of Finance & Admin. Jan 26 '24 Option Exercise 1.03 13,000 13,390 137,228 Jan 26 07:47 PM McNeill Jonathan Chief Business Officer Jan 26 '24 Sale 24.53 20,000 490,510 143,618 Jan 26 07:48 PM Scalzo Richard William SVP, Head of Finance & Admin. Jan 26 '24 Sale 24.34 13,000 316,420 124,228 Jan 26 07:47 PM Farwell Wildon Chief Medical Officer Jan 26 '24 Sale 25.00 100 2,500 168,996 Jan 26 07:49 PM Kersten Dirk Director Jan 09 '24 Buy 17.50 1,714,285 29,999,988 6,416,793 Jan 11 04:31 PM Brumm Joshua T CEO & President Jan 04 '24 Option Exercise 5.16 218,536 1,127,092 803,507 Jan 04 09:49 PM Beskrovnaya Oxana Chief Scientific Officer Jan 04 '24 Option Exercise 1.03 22,674 23,354 199,259 Jan 04 09:48 PM McNeill Jonathan Chief Business Officer Jan 04 '24 Option Exercise 0.73 2,009 1,467 145,627 Jan 04 09:47 PM Brumm Joshua T CEO & President Jan 04 '24 Sale 18.51 218,536 4,045,958 584,971 Jan 04 09:49 PM Beskrovnaya Oxana Chief Scientific Officer Jan 04 '24 Sale 18.13 42,453 769,673 156,806 Jan 04 09:48 PM McNeill Jonathan Chief Business Officer Jan 04 '24 Sale 18.04 2,009 36,242 143,618 Jan 04 09:47 PM Brumm Joshua T CEO & President Jan 03 '24 Option Exercise 1.03 51,183 52,718 636,154 Jan 04 09:49 PM Beskrovnaya Oxana Chief Scientific Officer Jan 03 '24 Option Exercise 1.03 45,326 46,686 221,911 Jan 04 09:48 PM Scalzo Richard William SVP, Head of Finance & Admin. Jan 03 '24 Option Exercise 1.03 13,000 13,390 137,228 Jan 04 09:46 PM McNeill Jonathan Chief Business Officer Jan 03 '24 Option Exercise 0.73 17,991 13,133 161,609 Jan 04 09:47 PM Brumm Joshua T CEO & President Jan 03 '24 Sale 19.28 51,183 986,957 584,971 Jan 04 09:49 PM Beskrovnaya Oxana Chief Scientific Officer Jan 03 '24 Sale 18.98 45,326 860,313 176,585 Jan 04 09:48 PM McNeill Jonathan Chief Business Officer Jan 03 '24 Sale 18.74 17,991 337,062 143,618 Jan 04 09:47 PM Scalzo Richard William SVP, Head of Finance & Admin. Jan 03 '24 Sale 18.81 13,000 244,530 124,228 Jan 04 09:46 PM McNeill Jonathan Chief Business Officer Jan 02 '24 Sale 13.10 11,900 155,890 143,618 Jan 04 09:47 PM Scalzo Richard William See Remarks Dec 14 '23 Sale 12.02 2,376 28,560 124,228 Dec 14 04:59 PM Farwell Wildon Chief Medical Officer Dec 12 '23 Sale 10.55 978 10,318 169,096 Dec 12 05:33 PM Brumm Joshua T See Remarks Dec 11 '23 Sale 10.72 7,585 81,311 584,971 Dec 12 05:33 PM Farwell Wildon Chief Medical Officer Dec 11 '23 Sale 10.72 1,688 18,095 170,074 Dec 12 05:33 PM HIGH SUSANNA GATTI Chief Operating Officer Dec 11 '23 Sale 10.72 1,616 17,324 187,882 Dec 12 05:34 PM Beskrovnaya Oxana Chief Scientific Officer Dec 11 '23 Sale 10.72 1,467 15,726 176,585 Dec 12 05:32 PM Scalzo Richard William See Remarks Dec 11 '23 Sale 10.72 1,380 14,794 126,604 Dec 12 05:35 PM McNeill Jonathan Chief Business Officer Dec 11 '23 Sale 10.72 1,245 13,346 155,518 Dec 12 05:34 PM Scalzo Richard William See Remarks Dec 06 '23 Sale 12.01 1,872 22,483 127,984 Dec 06 06:13 PM Scalzo Richard William See Remarks Dec 04 '23 Sale 12.01 681 8,179 129,856 Dec 06 06:13 PM HIGH SUSANNA GATTI Chief Operating Officer Nov 02 '23 Sale 7.40 9,939 73,549 94,605 Nov 02 05:16 PM Brumm Joshua T See Remarks Sep 18 '23 Sale 9.41 12,032 113,221 233,679 Sep 20 04:47 PM HIGH SUSANNA GATTI Chief Operating Officer Sep 18 '23 Sale 9.41 2,672 25,144 104,544 Sep 20 04:48 PM Beskrovnaya Oxana Chief Scientific Officer Sep 18 '23 Sale 9.41 1,436 13,513 84,334 Sep 20 04:47 PM Scalzo Richard William See Remarks Sep 18 '23 Sale 9.41 1,290 12,139 40,795 Sep 20 04:49 PM McNeill Jonathan Chief Business Officer Sep 18 '23 Sale 9.41 1,261 11,866 60,605 Sep 20 04:49 PM Brumm Joshua T See Remarks Sep 12 '23 Sale 10.41 7,672 79,866 245,711 Sep 13 07:50 PM Farwell Wildon Chief Medical Officer Sep 12 '23 Sale 10.41 1,707 17,770 89,250 Sep 13 07:56 PM HIGH SUSANNA GATTI Chief Operating Officer Sep 12 '23 Sale 10.41 1,635 17,020 107,216 Sep 13 07:51 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite